by Elena Iemma | Mar 29, 2024 | Featured, News
PROVIDENCE, RI, April 1, 2024 /PRNewswire/ — In the pursuit of developing novel biologic entities, scientists harnessing the power of AI and generative biology depend on computational tools for predicting and managing immunogenicity risk – a critical...
by Elena Iemma | Mar 26, 2024 | Thinking Out Loud -Blog
OK, sometimes, I am late to the party. Maybe … allowing ideas, like parties, to mature, means getting there at exactly the right time. That just happened with this article and I’d like to share it with you. It’s about Tregitopes, even though the...
by Elena Iemma | Mar 5, 2024 | Events
The Artificial Intelligence / Human Intelligence & Immunoinformatics Workshop will take place on June 13 and 14th at the South Street Landing Conference Center in Providence, Rhode Island. Purpose: This event aims to facilitate discussions and knowledge...
by Elena Iemma | Jun 27, 2023 | Uncategorized
Developing biologics? EpiVax’s High Throughput Immunogenicity Assessment provides a comprehensive assessment of potential clinical immunogenicity for large sets of biologic candidates. This approach allows preclinical researchers to compare the immunogenic...
by Elena Iemma | May 17, 2023 | Featured, News
PROVIDENCE, RI, May 17, 2023 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) is celebrating its 25th birthday by renewing the company’s commitment to improving human health everywhere while highlighting the development of groundbreaking tools by the company. In addition,...